Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
IndexS&P 500 P/E36.20 EPS (ttm)2.10 Insider Own1.54% Shs Outstand241.71M Perf Week3.18%
Market Cap17.87B Forward P/E17.28 EPS next Y4.41 Insider Trans-2.59% Shs Float231.12M Perf Month2.78%
Income515.10M PEG3.62 EPS next Q0.98 Inst Own98.21% Short Float1.94% Perf Quarter5.90%
Sales3.97B P/S4.50 EPS this Y1.88% Inst Trans-9.73% Short Ratio2.42 Perf Half Y1.12%
Book/sh19.84 P/B3.84 EPS next Y9.23% ROA5.80% Short Interest4.49M Perf Year-6.25%
Cash/sh8.23 P/C9.25 EPS next 5Y10.00% ROE10.57% 52W Range64.02 - 87.88 Perf YTD6.58%
Dividend Est.- P/FCF20.82 EPS past 5Y- ROI7.16% 52W High-13.35% Beta1.01
Dividend TTM- Quick Ratio3.18 Sales past 5Y7.03% Gross Margin54.59% 52W Low18.95% ATR (14)1.19
Dividend Ex-Date- Current Ratio3.89 EPS Y/Y TTM-46.37% Oper. Margin22.78% RSI (14)66.56 Volatility1.40% 1.72%
Employees6990 Debt/Eq0.55 Sales Y/Y TTM-11.12% Profit Margin12.98% Recom2.15 Target Price84.65
Option/ShortYes / Yes LT Debt/Eq0.55 EPS Q/Q36.50% Payout0.00% Rel Volume0.47 Prev Close75.88
Sales Surprise2.40% EPS Surprise3.17% Sales Q/Q-5.69% EarningsFeb 01 AMC Avg Volume1.86M Price76.15
SMA202.83% SMA504.63% SMA2002.55% Trades Volume1,417,898 Change0.36%
Date Action Analyst Rating Change Price Target Change
Jul-14-23Upgrade Needham Hold → Buy $95
Dec-07-22Initiated RBC Capital Mkts Sector Perform $75
Oct-13-22Initiated Mizuho Buy $75
Jul-20-22Initiated UBS Neutral $73
Jul-20-22Downgrade BofA Securities Buy → Neutral $81 → $75
Jul-18-22Downgrade BTIG Research Buy → Neutral
Apr-25-22Downgrade Wells Fargo Overweight → Equal Weight $75
Apr-04-22Downgrade Evercore ISI Outperform → In-line $80
Dec-15-21Downgrade Citigroup Buy → Neutral $85 → $78
Oct-15-21Resumed Cowen Outperform $83
Feb-21-24 09:00AM
Feb-18-24 01:26PM
Feb-06-24 10:43AM
Feb-05-24 03:31PM
10:40AM Loading…
Feb-03-24 12:08AM
Feb-02-24 12:52PM
Feb-01-24 05:35PM
04:10PM Loading…
Jan-31-24 11:17AM
Jan-30-24 07:29PM
Jan-29-24 09:16AM
Jan-25-24 11:00AM
Jan-22-24 05:45PM
Jan-20-24 03:19PM
Jan-19-24 09:00AM
Jan-18-24 11:30AM
Jan-17-24 12:10PM
Jan-16-24 05:45PM
08:08AM Loading…
Jan-11-24 08:08AM
Jan-09-24 05:45PM
Jan-08-24 09:00AM
Jan-07-24 04:00PM
Jan-04-24 08:33AM
Jan-02-24 05:45PM
Dec-28-23 04:28AM
Dec-27-23 05:45PM
Dec-20-23 05:45PM
Dec-18-23 07:39AM
Dec-14-23 05:45PM
Dec-11-23 06:55AM
Dec-07-23 03:37AM
Dec-05-23 09:00AM
Dec-03-23 05:25AM
Dec-01-23 06:25AM
Nov-30-23 06:00AM
Nov-28-23 05:27PM
Nov-25-23 03:04AM
Nov-24-23 09:00AM
Nov-22-23 12:13AM
Nov-21-23 08:15AM
Nov-14-23 05:03PM
Nov-13-23 09:00AM
Nov-10-23 05:12PM
Nov-09-23 05:30PM
Nov-06-23 09:57AM
Nov-02-23 10:00AM
Nov-01-23 09:00AM
Oct-30-23 05:45PM
Oct-27-23 09:03AM
Oct-23-23 05:45PM
Oct-20-23 09:00AM
Oct-16-23 05:45PM
Oct-12-23 08:33AM
Oct-10-23 08:30AM
Oct-09-23 05:45PM
Oct-05-23 08:00AM
Oct-02-23 05:45PM
Sep-29-23 08:00AM
Sep-28-23 09:16AM
Sep-27-23 09:00AM
Sep-25-23 05:45PM
Sep-22-23 11:50AM
Sep-21-23 08:30AM
Sep-20-23 11:10AM
Sep-15-23 09:00AM
Sep-11-23 05:45PM
Sep-05-23 05:45PM
Sep-04-23 09:00AM
Aug-31-23 11:31AM
Aug-30-23 08:00AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment focuses on products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment offers the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oberton Karleen MarieChief Financial OfficerJan 29Sale75.0014,9401,120,500103,916Jan 30 04:08 PM
Dockendorff Charles JDirectorJan 02Option Exercise38.447,551290,26017,482Jan 04 04:09 PM
Dockendorff Charles JDirectorJan 02Sale72.0016,0171,153,2241,465Jan 04 04:09 PM
GARRETT SCOTT TDirectorDec 11Sale68.7110,000687,11647,039Dec 13 04:07 PM
MACMILLAN STEPHEN PChairman, President and CEONov 29Option Exercise26.2147,7111,250,5051,286,799Dec 01 04:04 PM
MACMILLAN STEPHEN PChairman, President and CEONov 29Sale70.4147,7113,359,1881,239,088Dec 01 04:04 PM
Mitchell Essex DDiv. President, GYN SurgicalNov 21Sale71.857,500538,89012,827Nov 24 04:02 PM
GARRETT SCOTT TDirectorJun 15Sale79.7210,000797,24057,039Jun 20 05:03 PM
Mitchell Essex DDiv. President, GYN SurgicalMay 05Sale83.732,390200,1157,212May 09 04:18 PM